The present invention relates to the use of lipid containing particles, suchas liposomes, iscom and/or iscom matrix and posintros, comprising at least onelipid and at least one saponin for the preparation of a pharmaceutical for thetreatment of cancer. The saponins are preferably from Quillaja Saponaria Molin.Further, the particles are also delivery systems for one or several compoundsfor cancer treatment with complementary mechanisms. More, the invention discloseskit of parts comprising at least two parts, wherein one part comprising at leastone saponin fraction which is hydrophobic having a killing effect on cancer cell；and the other part comprising at least one saponin fraction which is comparativelyhydrophilic, stimulating and modulating the immune response.
